Tags

Type your tag names separated by a space and hit enter

Management of cardiovascular risk associated with insulin resistance, diabetes, and the metabolic syndrome.
Postgrad Med. 2010 May; 122(3):61-70.PM

Abstract

The metabolic syndrome is a cluster of symptoms that function as risk factors for cardiovascular disease (CVD), and its key components--diabetes, dyslipidemia, and hypertension--form a lethal combination. The incidence of obesity and other components of the metabolic syndrome is now at epidemic proportions, and current lifestyle trends suggest that it will continue to increase worldwide. In order to avert a major health crisis, physicians must take immediate steps to recognize and treat the metabolic syndrome and its components. Early diagnosis and therapeutic lifestyle changes should go hand-in-hand with individual and composite therapy for metabolic syndrome components to reduce CVD risk in affected individuals. This review provides a comprehensive overview of the diagnosis and treatment of the metabolic syndrome with a particular emphasis on reducing CVD risk.

Links

Publisher Full Text (DOI)

Authors+Show Affiliations

Mehta A
Department of Endocrinology Diabetes and Metabolism, Cleveland Clinic, Cleveland, OH 44195, USA. johnson1@cff.org

MeSH

Clofibric AcidDiabetes Mellitus, Type 2DyslipidemiasHumansHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic AgentsMetabolic Syndrome

Pub Type(s)

Journal Article

Language

eng

PubMed ID

20463415

Citation

Mehta, Adi. "Management of Cardiovascular Risk Associated With Insulin Resistance, Diabetes, and the Metabolic Syndrome." Postgraduate Medicine, vol. 122, no. 3, 2010, pp. 61-70.
Mehta A. Management of cardiovascular risk associated with insulin resistance, diabetes, and the metabolic syndrome. Postgrad Med. 2010;122(3):61-70.
Mehta, A. (2010). Management of cardiovascular risk associated with insulin resistance, diabetes, and the metabolic syndrome. Postgraduate Medicine, 122(3), 61-70. https://doi.org/10.3810/pgm.2010.05.2143
Mehta A. Management of Cardiovascular Risk Associated With Insulin Resistance, Diabetes, and the Metabolic Syndrome. Postgrad Med. 2010;122(3):61-70. PubMed PMID: 20463415.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Management of cardiovascular risk associated with insulin resistance, diabetes, and the metabolic syndrome. A1 - Mehta,Adi, PY - 2010/5/14/entrez PY - 2010/5/14/pubmed PY - 2010/6/9/medline SP - 61 EP - 70 JF - Postgraduate medicine JO - Postgrad Med VL - 122 IS - 3 N2 - The metabolic syndrome is a cluster of symptoms that function as risk factors for cardiovascular disease (CVD), and its key components--diabetes, dyslipidemia, and hypertension--form a lethal combination. The incidence of obesity and other components of the metabolic syndrome is now at epidemic proportions, and current lifestyle trends suggest that it will continue to increase worldwide. In order to avert a major health crisis, physicians must take immediate steps to recognize and treat the metabolic syndrome and its components. Early diagnosis and therapeutic lifestyle changes should go hand-in-hand with individual and composite therapy for metabolic syndrome components to reduce CVD risk in affected individuals. This review provides a comprehensive overview of the diagnosis and treatment of the metabolic syndrome with a particular emphasis on reducing CVD risk. SN - 1941-9260 UR - https://www.unboundmedicine.com/medline/citation/20463415/Management_of_cardiovascular_risk_associated_with_insulin_resistance_diabetes_and_the_metabolic_syndrome_ DB - PRIME DP - Unbound Medicine ER -